Tirzepatide (Compounded) dosage by bodyweight
Reference dose ranges scaled across bodyweight bands, anchored to the most-cited research dose (2500 mcg @ 75 kg). Educational only — never a recommendation.
| Bodyweight band | Reference dose range | At U-100 (1 mg/mL) | Vol. on U-100 (5 mg / 2 mL) | 5× t½ elapsed |
|---|---|---|---|---|
| <60 kg / <132 lb | 1558–2108 mcg | 1.56–2.11 mL | 62–84 units0.62–0.84 mL | — |
| 60–75 kg / 132–165 lb | 1913–2588 mcg | 1.91–2.59 mL | 77–104 units0.77–1.04 mL | — |
| 75–90 kg / 165–198 lb | 2338–3162 mcg | 2.34–3.16 mL | 94–127 units0.94–1.26 mL | — |
| 90–105 kg / 198–231 lb | 2763–3737 mcg | 2.76–3.74 mL | 111–150 units1.11–1.49 mL | — |
| >105 kg / >231 lb | 3188–4313 mcg | 3.19–4.31 mL | 128–173 units1.28–1.73 mL | — |
Volume column assumes a standard 5 mg vial reconstituted with 2 mL bacteriostatic water (concentration 2.5 mg/mL); insulin units shown for a U-100 syringe. No published half-life on file for Tirzepatide (Compounded); the elapsed-time column is hidden.
Tirzepatide (Compounded) by goal
Read Tirzepatide (Compounded)'s profile and dosing through a specific research-goal lens.
Educational use only
This calculator is provided for research and educational purposes. Outputs are derived from the values you enter. Always verify your math and consult a licensed physician before acting on any result.